PMID: 29498372Mar 3, 2018Paper

Proteflazid®: Clinical experience in children of young and preschool age - systematic review of postmarketing surveillance

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
Galina BeketovaNatalia Golovnia

Abstract

Scientific literature data on the experience of use of Proteflazid® (drops) and Immunoflazid® (syrup) for the treatment of viral diseases in children of the first six years of life are analysed in the article. A systematic review was conducted on the basis of postmarketing comparative clinical trials and long-term follow-up (during the period of 2002 to 2016) that involved about 1500 children (the intent-to-treat population comprised more than 800 of them). The safety and efficacy of the Proteflazid® (drops) and Immunoflazid® (syrup) usage in children for the treatment of viral infections have been proven.

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Clinical Pharmacology and Therapeutics
William L Holden, Linda J Scarazzini
Contemporary Clinical Trials
Venkatesan D VidiFrederic S Resnic
BMJ : British Medical Journal
S Voss, F Harris
British Journal of Clinical Pharmacology
R H Robson
© 2022 Meta ULC. All rights reserved